发明名称 Novel 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 molecules and uses therefor
摘要 The invention provides isolated nucleic acids molecules, designated 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 and 49933 nucleic acid molecules. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which a 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 gene has been introduced or disrupted. The invention still further provides isolated 25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 proteins, fusion proteins, antigenic peptides and anti-25869, 25934, 26335, 50365, 21117, 38692, 46508, 16816, 16839, 49937, 49931 or 49933 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
申请公布号 US2004157221(A9) 申请公布日期 2004.08.12
申请号 US20030377072 申请日期 2003.02.27
申请人 MILLENNIUM PHARMACEUTICALS, INC. 发明人 CURTIS RORY A. J.;LOGAN THOMAS JOSEPH;GLUCKSMANN MARIA ALEXANDRA;MEYERS RACHEL E.;WILLIAMSON MARK J.;RUDOLPH-OWEN LAURA A.;CHUN MIYOUNG;TSAI FONG-YING
分类号 A61K38/00;C07K14/705;C12N9/02;C12N9/12;C12N9/18;C12N9/20;C12N9/88;(IPC1-7):C12Q1/68;C07H21/04;C12N9/00;C12P21/02;C12N5/06;C07K14/47 主分类号 A61K38/00
代理机构 代理人
主权项
地址